London, UK, 29 APRIL 2025
A big congratulations to the Convatec team on the regulatory approval of ConvaNiox – a major milestone for nitric oxide-based wound care.
We are proud that this innovation began at 30 Technology, and it’s rewarding to see our former wound care platform now on its way to patients worldwide.
As we celebrate this milestone, 30 Technology remains dedicated to advancing our NO platform in other critical areas, and we look forward to the continued evolution of NO-based therapies.